Earnings Feed
Start Free
CRESCENT BIOPHARMA, INC.·4

Jun 23, 4:02 PM ET

Im Ellie Eunkyung 4

Research Summary

AI-generated summary

Updated

Crescent BioPharma (CBIO) CMO Im Ellie Eunkyung Sells 1,219 Shares

What Happened
Im Ellie Eunkyung, Chief Medical Officer of Crescent BioPharma (CBIO), sold 1,219 shares on June 22, 2026, for a weighted average price of $17.99, resulting in proceeds of approximately $21,930. This was a sale (not a purchase) and was made to satisfy tax withholding related to vested restricted stock units.

Key Details

  • Transaction date: 2026-06-22 (Form 4 filed 2026-06-23; appears timely).
  • Transaction type: Sale (code S).
  • Shares sold: 1,219; weighted average price reported $17.99; total proceeds ≈ $21,930.
  • Price range: sales occurred at prices between $16.88 and $18.86 (multiple transactions); the filing notes the weighted average and offers to provide per-price breakdown on request.
  • Reason/footnotes: Shares were automatically sold to satisfy tax withholding on RSUs granted Dec 15, 2025; sales were effected pursuant to a Rule 10b5-1 plan adopted Feb 25, 2026.
  • Shares owned after transaction: Not disclosed in this filing.

Context
Sales to cover tax withholding on vested awards are routine and do not necessarily signal a change in insider sentiment. The use of a Rule 10b5-1 plan indicates the trades were pre-planned to meet tax obligations.